Amneal Pharmaceuticals, Inc. ( AMRX) - Key Metrics
AMRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.60 | $0.11 | $0.42 | $0.28 |
| 2025Q3 | $2.50 | $0.01 | $0.38 | $0.33 |
| 2025Q2 | $2.31 | $0.07 | $0.27 | $0.18 |
| 2025Q1 | $2.24 | $0.04 | $0.02 | -$0.04 |
AMRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 28.14 |
| 2025Q3 | ? | 331.87 |
| 2025Q2 | ? | 28.31 |
| 2025Q1 | ? | 53.44 |
AMRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.85% | ? |
| 2025Q4 | 2.21% | ? |
| 2025Q3 | 3.29% | ? |
| 2025Q2 | 2.26% | ? |
| 2025Q1 | -0.42% | ? |
AMRX
Price: $13.52
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.22 USD
P/E Ratio: 62.36
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.8 million
Market Capitalization: 4.3 billion